Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 45 (PPIAP45)

Target
PPIAP45
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA), Other
01

Overview

Peptidylprolyl isomerase A pseudogene 45 (PPIAP45) is a human pseudogene related to the gene encoding peptidylprolyl isomerase A (PPIA, also known as cyclophilin A). PPIAP45 does not code for a functional protein, and like other pseudogenes, it is generally not considered a direct drug target or receptor. The biological function of PPIAP45 itself has not been established, but related PPIA pseudogenes have been shown to regulate gene expression through ceRNA (competing endogenous RNA) mechanisms, potentially by sponging microRNAs and influencing the expression of their parental gene or other genes. There is currently no evidence that PPIAP45 is involved in any specific disease or is actionable by drugs. PPIAP45 is instead recognized as part of the broader pseudogene transcriptome, which may play regulatory roles in cellular networks but is not itself a therapeutic target. PPIAP45 is listed as a pseudogene in major gene databases; it is not a protein-coding gene or established therapeutic target. There is no evidence of protein product, drug interaction, or biomarker role in the referenced literature or gene annotation resources for PPIAP45 itself. Related PPIA pseudogenes (such as PPIAP22) have been implicated in ceRNA regulatory networks, but this has not been specifically established for PPIAP45. These pseudogenes are not considered enzymes, receptors, or classical molecular targets. If PPIAP45 is required for structured data extraction or annotation, its status should be categorized as a regulatory pseudogene with presently undetermined, likely indirect, regulatory function.

Other names
Peptidylprolyl isomerase A (cyclophilin A) pseudogene 45PPIAP45
02

Biological functions

Regulatory RNA (possible competing endogenous RNA, ceRNA network)Gene expression regulation (potentially via miRNA interactions in analogy to other PPIA pseudogenes)
03

Disease associations

Other (no direct disease linkage established for PPIAP45, but parent gene PPIA and other PPIA pseudogenes implicated in cancer, immunity, and viral infection)

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 45 (PPIAP45).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 45 (PPIAP45).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call